|
COPS7B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.124100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.615800E-02 |
| Normal-vs-Stage2 |
4.703800E-01 |
| Normal-vs-Stage3 |
1.330570E-01 |
| Normal-vs-Stage4 |
2.220200E-04 |
| Stage1-vs-Stage2 |
4.907000E-01 |
| Stage1-vs-Stage3 |
8.888000E-01 |
| Stage1-vs-Stage4 |
5.559000E-03 |
| Stage2-vs-Stage3 |
5.853200E-01 |
| Stage2-vs-Stage4 |
1.013850E-02 |
| Stage3-vs-Stage4 |
7.863100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.661800E-02 |
| Normal-vs-AfricanAmerican |
1.621670E-03 |
| Normal-vs-Asian |
5.828700E-04 |
| Caucasian-vs-AfricanAmerican |
9.759700E-03 |
| Caucasian-vs-Asian |
5.702100E-03 |
| AfricanAmerican-vs-Asian |
1.576020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.181800E-01 |
| Normal-vs-Female |
3.557400E-04 |
| Male-vs-Female |
4.772100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.117570E-01 |
| Normal-vs-Age(41-60Yrs) |
2.944300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.126200E-02 |
| Normal-vs-Age(81-100Yrs) |
6.680600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.357200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.847600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.961000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.130800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.670800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.405800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.382500E-02 |
| Normal-vs-Grade 2 |
1.159030E-01 |
| Normal-vs-Grade 3 |
1.193600E-01 |
| Normal-vs-Grade 4 |
9.80579999999565E-05 |
| Grade 1-vs-Grade 2 |
1.834180E-01 |
| Grade 1-vs-Grade 3 |
1.325780E-01 |
| Grade 1-vs-Grade 4 |
8.174200E-01 |
| Grade 2-vs-Grade 3 |
8.753800E-01 |
| Grade 2-vs-Grade 4 |
1.395620E-03 |
| Grade 3-vs-Grade 4 |
1.722960E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.279400E-01 |
| Normal-vs-ccB subtype |
1.963780E-02 |
| ccA subtype-vs-ccB subtype |
3.553900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.792400E-02 |
| Normal-vs-N1 |
2.438300E-03 |
| N0-vs-N1 |
1.062740E-03 |
|
|
